Sintetica
Privately held: no public share price · Switzerland
Assets
(1 total)
1Total Assets
1Approved
0Phase 3 / Filed
0Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
| Approved | Voltage-gated sodium channels (Nav) on sensory nerve membranesSmall molecule | Ocular Anesthesia Ocular Surface Anesthesia |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Regulatory and conference events
(1)
Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.
Recent
20 August 2026Topline resultchloroprocaineIHEEZO contralateral-eye study vs proparacaine in intravitreal injections
Financial reports
No financial reports recorded.